dr. bekaii-saab on dosing strategies with regorafenib in crc
Published 8 years ago • 51 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:32
dr. bekaii-saab discusses qol with regorafenib dose escalation in mcrc
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
6:33
patient selection for regorafenib in crc